FDA Inspection
REVIN LABS PRIVATE LIMITEDREVIN LABS PRIVATE LIMITED – FDA Inspection, Jan 25, 2023
Record Details
This FDA Inspection record concerns REVIN LABS PRIVATE LIMITED, with an inspection on January 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 317267d8-03f4-4bbe-8c5a-5ffd4cb2bd29
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1196673
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.165(e)Test methods
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.